Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Negative equity NBB
More debt than assets in 4 of the last 4 fiscal years.
-
Tight liquidity NBB
Cash and receivables cover 55 % of short-term debt in 2025; threshold 65 %.
Financials
Financial year 2025
PHARMACIE SAINTE-WALBURGE from Soumagne, company number BE0871780471, closed financial year 2025 with a result of € 42,921 after tax. For that financial year PHARMACIE SAINTE-WALBURGE recorded a gross margin of € 240,091 and equity of € -19,030. Compared with financial year 2024, the result moved from € -3,277 to € 42,921. Profitable, and profit is growing. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 30, 2026.
€ -19,030
▲ € 42,921 vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 42,921
▲ still € 3,277 loss in 2024
Profit after tax over the fiscal year.
€ 59,635
▲ 45% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € -39,030.
People and assets in 2025
3.4
▼ 0.5 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 138,267
▼ 20% vs 2024
€ 40,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 168,616
▼ 28% vs 2024
€ 32,412 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.
€ 129,761
▲ 29% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 22,483
▲ 3% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 207,454 | € 208,259 | € 223,770 | € 240,091 | ▲ 7% |
| Profit after taxes | € 985 | € -5,378 | € -3,277 | € 42,921 | ▲ € 46,198 |
| Equity | € -53,297 | € -58,675 | € -61,952 | € -19,030 | ▲ € 42,921 |
| Total debts | € 505,405 | € 436,667 | € 428,480 | € 381,430 | ▼ 11% |
| Cash | € 52,398 | € 18,354 | € 41,090 | € 59,635 | ▲ 45% |
| Retained profit | € -73,297 | € -78,675 | € -81,952 | € -39,030 | ▲ € 42,921 |
| Bank debt | € 312,410 | € 240,784 | € 234,726 | € 168,616 | ▼ 28% |
| Balance sheet total | € 452,108 | € 377,992 | € 366,528 | € 362,400 | ▼ 1% |
| Employees (FTE) | 3.1 | 3.9 | 3.9 | 3.4 | ▼ 0.5 |
Key figures of PHARMACIE SAINTE-WALBURGE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMACIE SAINTE-WALBURGE?
What happened at PHARMACIE SAINTE-WALBURGE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 42,921. Source: NBB ↗
- New establishment in Liège. KBO
- Start of the company according to the CBE. KBO
In short
From € 985 profit in 2022 to € 42,921 profit in 2025.
Paid € 7,237 in corporate taxes since 2022.
Best year ever: 2025, with € 42,921 profit.
On average € 70,600 of value added per employee in 2025.
A new publication or filing at PHARMACIE SAINTE-WALBURGE? We notify you, reason included.
Follow PHARMACIE SAINTE-WALBURGEDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind PHARMACIE SAINTE-WALBURGE are PHARMA INVEST MANAGEMENT SRL and HUBERT PIRENNE. The same people are also behind PHARMACIE ALLEUR and PHARMACIE HERSTAL. PHARMA INVEST MANAGEMENT SRL is also behind PHARMA-FORME. HUBERT PIRENNE is also behind GOLF CLUB & ACADEMY BEAUFAYS, PHARMA INVEST MANAGEMENT and HP PHARMA.
Directors
According to the 2025 annual accounts
Manager · represented by Marielle Demonceau
Also active at: PHARMA-FORME, PHARMACIE ALLEUR, PHARMACIE HERSTAL
HUBERT PIRENNE
Director
Also active at: GOLF CLUB & ACADEMY BEAUFAYS, PHARMACIE ALLEUR, PHARMACIE HERSTAL, PHARMA INVEST MANAGEMENT, HP PHARMA
Establishments
Establishment units
Physical locations of this company
Rue Louis Pasteur 3
4630 Soumagne
Rue Sainte-Walburge 11
4000 Liège
Active since 1 March 2005
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 2 companies are registered at this address.
All companies at this address →What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0871.780.471
- VAT number
- BE 0871.780.471
- Registered office
- Rue Louis Pasteur 3, 4630 Soumagne
- Names & denominations
- PHARMACIE SAINTE-WALBURGE
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 9 February 2005
- Peppol
- Active · Active since 3 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten
Apothekers